Antimicrobial effects of lidocaine, bicarbonate, and epinephrine.
Williams
B J
BJ
Department of Dermatology, Indiana University Medical Center, Indianapolis 46202, USA.
Hanke
C W
CW
Bartlett
M
M
D000779:Anesthetics, Local / Q000008:administration & dosage / Q000494:pharmacology*; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001231:Aspergillus flavus / Q000187:drug effects / Q000254:growth & development; D001639:Bicarbonates / Q000008:administration & dosage / Q000494:pharmacology*; D001758:Blastomyces / Q000187:drug effects / Q000254:growth & development; D002021:Buffers; D002176:Candida albicans / Q000187:drug effects / Q000254:growth & development; D015169:Colony Count, Microbial; D003455:Cryptococcus neoformans / Q000187:drug effects / Q000254:growth & development; D004305:Dose-Response Relationship, Drug; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology*; D005670:Fusarium / Q000187:drug effects / Q000254:growth & development; D006658:Histoplasma / Q000187:drug effects / Q000254:growth & development; D006801:Humans; D008012:Lidocaine / Q000008:administration & dosage / Q000494:pharmacology*; D011550:Pseudomonas aeruginosa / Q000187:drug effects / Q000254:growth & development; D013175:Sporothrix / Q000187:drug effects / Q000254:growth & development; D013211:Staphylococcus aureus / Q000187:drug effects / Q000254:growth & development; D013997:Time Factors; D014662:Vasoconstrictor Agents / Q000008:administration & dosage / Q000494:pharmacology*
D000779:Anesthetics, Local; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D001639:Bicarbonates; D002021:Buffers; D014662:Vasoconstrictor Agents; D008012:Lidocaine; D004837:Epinephrine